These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6370314)

  • 1. Receptor-binding kinetics of A-14 and A-19 125I-labelled insulin.
    Watanabe N; Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y
    Biochim Biophys Acta; 1984 Apr; 798(3):313-6. PubMed ID: 6370314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of insulin receptors on heterogeneous eukaryotic cell populations with fluorochrome-conjugated insulin and fluorescence-activated cell sorter. Advantages and limitations to the 125I-labelled insulin methodology.
    Due C; Linnet K; Langeland Johansen N; Olsson L
    Diabetologia; 1985 Oct; 28(10):749-55. PubMed ID: 2415418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.
    Taylor SI; Leventhal S
    J Clin Invest; 1983 Jun; 71(6):1676-85. PubMed ID: 6345588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin binding and degradation by human erythrocytes at physiological temperature.
    Gambhir KK; Nerurkar SG; Das PD; Archer JA; Henry WL
    Endocrinology; 1981 Nov; 109(5):1787-9. PubMed ID: 7028468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated degradation by rat adipocytes: comparison of A-14 with A-19 125I-labelled insulin.
    Watanabe N; Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y
    Endocrinol Jpn; 1984 Jun; 31(3):321-6. PubMed ID: 6389102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.
    Green A; Frank BH; Rubenstein A; Tager H; Olefsky JM
    Endocrinology; 1983 Dec; 113(6):1963-71. PubMed ID: 6357764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity alteration of insulin receptor induced by a phorbol ester.
    Grunberger G; Gorden P
    Am J Physiol; 1982 Oct; 243(4):E319-24. PubMed ID: 6751097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship tothe kinetic properties of the hormone- receptor interaction.
    Simon J; Freychet P; Rosselin G; DeMeyts P
    Endocrinology; 1977 Jan; 100(1):115-21. PubMed ID: 830534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin binding, internalization, and receptor regulation in cultured human fibroblasts.
    Baldwin D; Prince M; Tsai P; Johnson C; Lotan R; Rubenstein AH; Olefsky JM
    Am J Physiol; 1981 Sep; 241(3):E251-60. PubMed ID: 7025657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of insulin receptors on foetal-mouse brain-cortical cells.
    Van Schravendijk CF; Hooghe-Peters EL; De Meyts P; Pipeleers DG
    Biochem J; 1984 May; 220(1):165-72. PubMed ID: 6378183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.
    Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y; Inouye K
    Biochem J; 1982 Sep; 206(3):597-603. PubMed ID: 6756393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pH accelerates dissociation of receptor-bound insulin.
    Marshall S; Podlecki DA; Olefsky JM
    Endocrinology; 1983 Jul; 113(1):37-42. PubMed ID: 6345144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin binding and degradation in short time incubation at 37 C.
    Cresto JC; Camberos MC; Zúccolo A; Justel E; Basabe JC
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):343-54. PubMed ID: 6242261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin.
    Carpentier JL; Halban PA; Renold AE; Orci L
    Diabetes Care; 1981; 4(2):220-2. PubMed ID: 7011731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of human erythrocyte insulin binding sites.
    Okada Y
    Acta Med Okayama; 1981 Apr; 35(2):125-35. PubMed ID: 6456644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.
    Wang CC; Goldfine ID; Fujita-Yamaguchi Y; Gattner HG; Brandenburg D; De Meyts P
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8400-4. PubMed ID: 3054887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptors convert to a higher affinity state subsequent to hormone binding. A two-state model for the insulin receptor.
    Corin RE; Donner DB
    J Biol Chem; 1982 Jan; 257(1):104-10. PubMed ID: 7031059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Lindskov HO; Sonne O; Gliemann J
    Diabetologia; 1981 Jun; 20(6):636-41. PubMed ID: 7021280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.